Daiwa Securities Upgrades Edwards Lifesciences Outperform From Neutral, Adjusts Price Target to $72 From $87
Daiwa Securities Upgrades Edwards Lifesciences Outperform From Neutral, Adjusts Price Target to $72 From $87
大和证券将爱德华生命科学评级由中立升级为跑赢大盘,并将目标股价从87美元调整为72美元。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册